CAS 1496395-30-2
:1,2,4-Triazolo[4,3-a]pyrazine-7(8H)-acetic acid, 5,6-dihydro-3-(trifluoromethyl)-
Description:
1,2,4-Triazolo[4,3-a]pyrazine-7(8H)-acetic acid, 5,6-dihydro-3-(trifluoromethyl)- is a heterocyclic compound characterized by its complex ring structure, which includes both triazole and pyrazine moieties. This compound features a trifluoromethyl group, which significantly influences its chemical reactivity and biological activity. The presence of the acetic acid functional group suggests potential for hydrogen bonding and solubility in polar solvents. Its unique structure may impart specific pharmacological properties, making it of interest in medicinal chemistry. The compound is likely to exhibit moderate to high stability under standard conditions, although the trifluoromethyl group can enhance its lipophilicity and metabolic stability. Additionally, the presence of multiple nitrogen atoms in the ring structure may contribute to its ability to interact with biological targets, potentially leading to applications in drug development. As with many heterocycles, the synthesis and characterization of this compound would require careful consideration of reaction conditions to ensure the desired product is obtained.
Formula:C8H9F3N4O2
Synonyms:- Sitagliptin Impurity 194
- 2-(3-(Trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)acetic acid
- Pyridoxine Impurity 54
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 1 products.
